2015
DOI: 10.4172/2161-1041.1000154
|View full text |Cite
|
Sign up to set email alerts
|

Molecular and Phylogenetic Study of Bm86 Gene Ortholog from Hyalomma excavatum Tick from Tunisia: Taxonomic and Immunologic Interest

Abstract: In order to assess the taxonomic and immunologic interest of Bm86 orthologs of Hyalomma ticks, partial sequence of Bm86 gene was amplified and sequenced. The sequences were isolated from three engorged Hyalomma excavatum females (Ariana strain, Tunisia). The analysis of nucleotide sequences showed increasing diversity rates of 0.26, 2.36, 4.97 and 6.02% between analyzed sequences and those isolated from H. excavatum specimen from a laboratory colony (Sousse strain, Tunisia), H. anatolicum, H. marginatum and H.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…marginatum marginatum and Hy. scupense ticks [ 191 ]. Analysis of obtained amino acid sequences showed a high diversity of 33–34% in Bm86 and Hy.…”
Section: Anaplasmosis Control In Africamentioning
confidence: 99%
See 1 more Smart Citation
“…marginatum marginatum and Hy. scupense ticks [ 191 ]. Analysis of obtained amino acid sequences showed a high diversity of 33–34% in Bm86 and Hy.…”
Section: Anaplasmosis Control In Africamentioning
confidence: 99%
“…Analysis of obtained amino acid sequences showed a high diversity of 33–34% in Bm86 and Hy. excavatum orthologues (He86-A1/A2/A3), implying a reduction in the efficacy of the Bm86-based commercial and experimental vaccines [ 191 ]. A limited 10.2% amino acid diversity between Hd86-A1 used in the experimental vaccine against Hy.…”
Section: Anaplasmosis Control In Africamentioning
confidence: 99%
“…Amino acid sequence comparison between Bm86 and H. excavatum orthologues He86-A1/A2/A3 revealed high diversity (33–34%), which could decrease the efficacy of vaccination by commercial and experimental vaccines based on Bm86. However, there was limited (10.2%) amino-acid diversity between Hd86-A1 used in an experimental vaccine against H. scupense and He86-A1/A2/A3, suggesting that the Hd86-A1 vaccine candidate might be more appropriate to target the H. excavatum tick than the corresponding Bm86 vaccines [ 153 ].…”
Section: Anti-tick Vaccines In Africamentioning
confidence: 99%